Transchem Ltd (TRANSCHEM) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Transchem Ltd on NSE and BSE, with an AI summary of each filing.
Please refer the attached Monitoring Agency Report for the quarter ended September 30, 2026.
Others (Uncategorized) · 05 Nov 2026, 2:01 am
Transchem Limited Q2FY27 Warrant Proceeds Monitoring Agency Report Acuité Ratings reported zero deviations in Transchem Limited's warrant proceeds utilization for the quarter ended 30th Sep'26. Out of the total INR 461.25 Cr preferential warrant issue (6.15 Cr warrants at INR 75.00 each), the company received 25% upfront funds of INR 115.31 Cr. During the quarter, INR 26.02 Cr was deployed toward acquiring a 100% equity stake in Greshma Shares & Stocks Limited. The remaining INR 89.29 Cr unutilized proceeds are parked in HDFC Bank accounts (INR 59.29 Cr) and fixed deposits (INR 30.00 Cr).
Please refer the attached intimation.
Financial Result · 04 Nov 2026, 11:53 pm
Transchem Reports H1 FY27 Results and Consolidates Newly Acquired Subsidiary Transchem Limited reported consolidated total income of ₹506.89 lakhs and net profit of ₹205.13 lakhs for Q2 ended 30th Sep'26, driving H1 FY27 net profit to ₹547.24 lakhs (basic EPS ₹4.47). Standalone Q2 net profit surged 198.4% YoY to ₹202.65 lakhs. Following the acquisition of a 100% stake in Greshma Shares & Stocks on 17th Aug'26 for ₹26.02 crore, funded via warrant proceeds (₹115.31 crore total raised), the company presented its first consolidated financial statements with unutilized funds placed in temporary investments.
Please refer the attached intimation.
Outcome · 04 Nov 2026, 11:32 pm
Transchem Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 92.6 ■ EBITDA: -120 (-60.8% YoY | -70.6% QoQ) ■ EBITDA Margin (%): -129 ■ PAT: 205 (+202.0% YoY | -40.0% QoQ) ■ EPS (INR): 0.32 (-42.9% YoY | -43.9% QoQ)
Transchem Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve the Un-Audited Financial Results ....
Intimation · 04 Nov 2026, 5:30 am
Transchem Schedules Board Meeting to Approve Q2 FY27 Financial Results Transchem Limited has scheduled a meeting of its Board of Directors on 4th Nov'26 to consider and approve the un-audited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. In compliance with insider trading regulations, the trading window for all designated persons and their immediate relatives has been closed effective 1st Oct'26 and will remain shut until 48 hours following the public dissemination of the financial results.
Please refer the attached intimation.
Annual General Meeting · 29 Sept 2026, 8:05 pm
Transchem 49th AGM: Key Business Approvals and Strategic Expansion Transchem Limited released the proceedings of its 49th AGM held on 5th Sep'26. Shareholders unanimously approved all three ordinary resolutions with 100% votes in favor, including the adoption of audited financial statements for FY26, the re-appointment of director Mahesh Suresh Rananavre, and material related-party transactions with Crest Ventures Limited. Management highlighted strategic milestones achieved during FY26, notably the acquisition of SEBI-registered stockbroker Greshma Shares & Stocks Limited and a warrant allotment, focusing forward efforts on integration, technology enhancements, and evaluating growth opportunities.
Please refer the attached intimation.
Annual General Meeting · 07 Sept 2026, 11:16 pm
Transchem 49th AGM: All Ordinary Resolutions Passed with 100% Majority Transchem Limited announced the voting results and scrutinizer’s report for its 49th AGM held on 5th Sep'26. Shareholders approved all three ordinary resolutions with 100% majority: adoption of audited FY26 financial statements, re-appointment of Director Mahesh Suresh Rananavre, and approval of material related party transactions with Crest Ventures Limited. For the related party transaction, 304,358 valid votes were cast in favor, while 1,349,329 votes cast by an interested related party were treated as invalid. Total voting turnout reached 69.96% for standard resolutions.
Please refer the attached intimation.
Annual General Meeting · 05 Sept 2026, 5:37 pm
Transchem Completes Greshma Acquisition and Pivots to Financial Services Transchem Limited's 49th AGM on 5th Sep'26 outlined its transition into financial services following its completed acquisition of SEBI-registered stockbroker Greshma Shares & Stocks Limited. Authorized share capital expanded from INR 30cr to INR 75cr, and convertible warrants were allotted at INR 75 per warrant (receiving 25% upfront). For FY25–26, revenue from operations was Nil due to wound-down trading, while other income reached INR 926.08 lakhs, yielding PAT of INR 429.51 lakhs. As of 31st Mar'26, equity stood at ~INR 83.58cr with zero debt.
Please refer the attached intimation.
Others (Uncategorized) · 17 Aug 2026, 11:39 pm
Transchem Acquires 100% of Greshma Shares and Stocks Transchem Limited announced on 17 Aug '26 it acquired 100% of Greshma Shares and Stocks Limited (GSSL) for a total consideration of INR 25.91 Cr. The all-cash deal involved purchasing 1,55,16,000 shares at INR 16.70 per share. Upon completion, GSSL becomes a wholly-owned subsidiary of Transchem. This strategic acquisition facilitates Transchem's entry into the financial services sector, leveraging GSSL's stock broking and depository services business. GSSL reported a turnover of INR 5.98 Cr for the year ended 31 Mar '26.
Please refer the attached intimation.
Others (Uncategorized) · 17 Aug 2026, 11:37 pm
Transchem Acquires 100% of Greshma Shares and Stocks Transchem Limited has acquired 100% of Greshma Shares and Stocks Limited (GSSL) for INR 25.91 crore, effective 17 Aug'26. The all-cash deal involved purchasing 1,55,16,000 shares at INR 16.70 per share. GSSL, a stock broking and depository services firm, will become a wholly-owned subsidiary. For FY ended 31 Mar'26, GSSL reported turnover of INR 5.98 crore and a net worth of INR 21.32 crore. The acquisition marks Transchem's strategic entry into the financial services sector to broaden its revenue base.
Please refer the attached Monitoring Agency Report for the quarter ended June 30, 2026.
Others (Uncategorized) · 10 Aug 2026, 11:16 pm
Transchem Reports No Utilization of Preferential Issue Proceeds in Q1 FY27 For Q1 FY27 ending Jun 30, '26, Transchem reported no deviation in the use of proceeds from its preferential warrant issue. The company has raised INR 115.31 Cr, which is 25% of the total issue size of INR 461.25 Cr. The entire amount remains unutilized and is temporarily deployed in fixed deposits (INR 25 Cr), liquid mutual funds (INR 15 Cr), and bank accounts (INR 75.31 Cr). Utilization for stated objectives, including strategic acquisitions and technology development, is planned in a phased manner.
Please refer the attached intimation.
Transcript · 10 Aug 2026, 11:09 pm
Transchem Amends Code of Conduct for Prevention of Insider Trading Transchem Limited's Board of Directors approved an amendment to its ‘Code of Conduct for Prevention of Insider Trading’ on 10 Aug’26. This action is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The revised code supersedes all previous versions and outlines updated protocols, trading restrictions, reporting requirements for Designated and Connected Persons, and procedures for handling unpublished price-sensitive information (UPSI). The updated policy is effective immediately, reinforcing the company's governance framework.
Please refer the attached intimation.
Financial Result · 10 Aug 2026, 11:02 pm
Transchem Reports Strong Q1 FY27 Results and Amends Insider Trading Code Transchem Limited reported robust Q1 FY27 results with net profit surging 244.4% YoY to ₹342.11 Lakhs on total income of ₹511.36 Lakhs, up 212.6% YoY. Profit before tax stood at ₹435.21 Lakhs, a 222.1% YoY increase. Basic EPS for the quarter ended Jun 30, ‘26, was ₹2.79, compared to ₹0.81 in Q1 FY26. Sequentially, net profit rose 63.4% QoQ. The Board also approved amendments to the 'Code of Conduct for Prevention of Insider Trading' and authorized the publication of the financial results.
Please refer the attached intimation.
Outcome · 10 Aug 2026, 10:55 pm
Transchem Ltd - Financial Result for the Quarter ended 30th Jun'26 (Standalone, INR Lakh) ■ Revenue: 0.0 ■ EBITDA: -70.1 (-146.6% YoY | +46.5% QoQ) ■ EBITDA Margin (%): 0.0 ■ PAT: 342 (+244.4% YoY | +63.4% QoQ) ■ EPS (INR): 0.57 (-29.6% YoY | -66.7% QoQ)
Transchem Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve the Un-audited Financial Results ....
Intimation · 10 Aug 2026, 5:30 am
Transchem Ltd Board to Approve Q1FY27 Results on 10th August 2026 Transchem Limited (BSE: 500422) has scheduled a Board of Directors meeting on 10 Aug'26 to consider and approve its un-audited financial results for the quarter ending 30 Jun'26. In compliance with insider trading regulations, the trading window for designated persons has been closed from 01 Jul'26 and will reopen 48 hours after the financial results are made public.
Please refer the attached intimation.
Transcript · 31 Jul 2026, 5:20 pm
Transchem Announces 49th Annual General Meeting and FY26 Annual Report Transchem Limited has scheduled its 49th Annual General Meeting (AGM) for 5th Sep'26 at 11:00 a.m. IST via video conference. The notice and the Annual Report for FY 2025-26 are being dispatched electronically. Shareholders without registered emails can access the documents on the company's website. A special one-year window from 5th Feb'26 to 4th Feb'27 allows investors to re-lodge physical share transfer deeds that were previously rejected before 1st Apr'19, providing a resolution path for documentation deficiencies.
Please refer the attached intimation.
Others (Uncategorized) · 31 Jul 2026, 5:17 pm
Please refer the attached intimation.
Annual General Meeting · 31 Jul 2026, 5:13 pm
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bakkt Opco Holdings, LLC
Acquisition/ Disposal of Shares · 05 Jun 2026, 8:16 pm
Bakkt Opco Acquires Warrants Representing 64.42% Diluted Stake in Transchem Bakkt Opco Holdings, LLC acquired 4,75,00,000 warrants in Transchem Limited via a preferential allotment on 3rd Jun'26. This acquisition represents a 64.42% stake in Transchem's total diluted share capital, assuming full conversion. Each warrant is convertible into one fully paid-up equity share of Rs. 10/- within 18 months. Before this transaction, Bakkt Opco held no shares or warrants in the company. Transchem's post-allotment diluted equity capital will increase to Rs. 73.74 crore from Rs. 12.24 crore pre-allotment.
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pishu V Chainani
Acquisition/ Disposal of Shares · 05 Jun 2026, 8:07 pm
Pishu V. Chainani Acquires Warrants for 19.51% Diluted Stake in Transchem On 03 Jun'26, non-promoter Pishu V. Chainani acquired 1.20 crore warrants of Transchem Ltd. (BSE: 500422) via preferential allotment. Each warrant is convertible into one equity share (FV Rs. 10) within 18 months. This acquisition represents a potential 19.51% stake in the company's total diluted share capital. Before this transaction, the acquirer held no shares or voting rights. The company's equity capital remains Rs. 12.24 crore post-allotment, but total diluted share capital would increase to Rs. 73.74 crore upon full conversion.
Please refer the attached intimation.
Others (Uncategorized) · 03 Jun 2026, 10:58 pm
Transchem Approves Preferential Allotment of 6.15 Crore Warrants at Rs. 75 Transchem's committee on Jun 03, '26, approved the preferential allotment of 6.15 crore warrants at an issue price of Rs. 75 each, aggregating to Rs. 461.25 crore. The company received the 25% upfront payment of Rs. 18.75 per warrant, totaling Rs. 115.31 million. Allottees are from the non-promoter category, with Bakkt Opco Holdings receiving the largest share (4.75 crore warrants). Each warrant is convertible into one equity share within 18 months. Upon full conversion, these allottees would hold 83.40% of the company.
Please refer the attached intimation.
Others (Uncategorized) · 03 Jun 2026, 10:55 pm
Transchem Allots 6.15 Crore Warrants via Preferential Issue On Jun 03, '26, Transchem allotted 6,15,00,000 warrants on a preferential basis at an issue price of Rs. 75 each, aggregating up to Rs. 461.25 crore. The company received an upfront payment of 25% (Rs. 18.75 per warrant), totaling Rs. 115.31 crore. Each warrant is convertible into one equity share within 18 months. Allottees are non-promoters, with Bakkt Opco Holdings, LLC being the largest, subscribing to 4,75,00,000 warrants. Upon full conversion, these allottees would collectively hold 83.40% of the expanded share capital.
Please refer the attached intimation.
Transcript · 22 May 2026, 5:02 pm
Transchem Receives BSE Approval for Preferential Warrant Issue Transchem Ltd. announced on 22 May'26 that it has received in-principle approval from BSE for its preferential issue. The approval, granted on 21 May'26, is for 6,15,00,000 warrants at Rs. 10/- each. This follows the company's initial intimation on 21 Nov'25. With necessary regulatory approvals now in place, Transchem will proceed with the consummation of the issue. The capital infusion is a key event for the company, potentially impacting equity structure and funding for future activities.
Please refer the attached intimation.
Transcript · 21 May 2026, 6:58 pm
Transchem Clarifies Use of Proceeds from Preferential Warrant Issue Transchem provided additional details on its preferential issue, clarifying the utilization of Rs. 115 Cr for General Corporate Purposes (GCP) over 6-18 months. The company also confirmed that proceeds for strategic acquisitions will be used solely in the broking and allied financial services sector, with targets intended to become subsidiaries. One allottee, Bakkt Opco Holdings, LLC, is controlled by NYSE-listed Bakkt, Inc. (BKKT), exempting it from certain SEBI beneficial owner verification requirements.
<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> ....
Others (Uncategorized) · 11 May 2026, 5:52 pm
Transchem Confirms Non-Applicability of Large Corporate Framework for FY26 Transchem Limited (SCRIP CODE: 500422) filed a declaration on 11 May'26, confirming it does not qualify as a Large Corporate for the financial year ended 31 Mar'26. This is based on applicability criteria outlined in SEBI circulars. Consequently, the mandatory borrowing requirements through debt securities under the Large Entities Framework are not applicable to the company for FY26. The filing shows no incremental borrowing and no mandatory debt borrowing obligations for the period.
Re-appointment of M/s. L. T. Jadav & Co., Chartered Accountants as the Internal Auditors of the Company for the F.Y. 2026-2027
Change in Management · 05 May 2026, 11:36 pm
Transchem Re-appoints L. T. Jadav & Co. as Internal Auditors Transchem Limited's board approved the re-appointment of M/s. L. T. Jadav & Co., Chartered Accountants, as the company's Internal Auditors on 05 May'26. The appointment is for the financial year 2026-2027. The firm, led by proprietor Mr. Lalitchandra Tribhovandas Jadav, is a CA practice established since 1985 with extensive experience in audit and tax-related assignments. This decision ensures continuity in the company's internal audit function, a routine corporate governance matter with no disclosed conflicts of interest.